Increased susceptibility of copper-deficient neuroblastoma cells to oxidative stress-mediated apoptosis

Free Radical Biology and Medicine

Volumn 30, Issue 10, 2001, Pages 1177-1187

  Rossi, Luisa ^a,b   Marchese, Eliana ^a   Lombardo, Marco F ^a   Rotilio, Giuseppe ^a,b   Ciriolo, Maria R ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

Apoptosis; Copper depletion; Free radicals; Neuroblastoma; Neurodegeneration; Oxidative stress

Indexed keywords

CASPASE 3; CATALASE; CHELATING AGENT; COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOCHROME C OXIDASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LACTATE DEHYDROGENASE; PARAQUAT; PROTEIN BCL 2; PROTEIN P53; PUROMYCIN; TRIENTINE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; COPPER DEFICIENCY; DISEASE PREDISPOSITION; ENZYME SPECIFICITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE DEGENERATION; NEUROBLASTOMA; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM;

APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASES; CHELATING AGENTS; COPPER; ELECTRON TRANSPORT COMPLEX IV; ENZYME ACTIVATION; GLUTATHIONE; HUMANS; NEUROBLASTOMA; OXIDATIVE STRESS; PARAQUAT; PROTO-ONCOGENE PROTEINS C-BCL-2; PUROMYCIN; SUPEROXIDE DISMUTASE; TRIETHYLENETETRAMINE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 0035873972     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(01)00533-0     Document Type: Article

References (49)

1. Halliwell B., Gutteridge J.M.C. Role of free radicals and catalytic metal ions in human disease an overview . Methods Enzymol. 186:1990;1-85.
2. Prohaska J.R., Bailey W.R. Persistent regional changes in brain copper, cuproenzymes and catecholamines following perinatal copper deficiency in mice. J. Nutr. 123:1993;1226-1234.
3. Tümer Z., Horn N. Menkes disease recent advances and new aspects . J. Med. Genet. 34:1997;265-274.
4. Wagonner D.J., Bartnikas T.B., Gitlin J.D. The role of copper in neurodegenerative disease. Neurobiol. Dis. 6:1999;221-230.
5. Multhaup G., Schliksupp A., Hesse L., Beher D., Ruppert T., Masters C.L., Beyreuther K. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science. 271:1996;1406-1409.
6. Parker W.D., Filley C.M., Parks J.K. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology. 40:1990;1302-1303.
7. Kish S.J., Mastrogiacomo F., Guttman M., Furukawa Y., Taanman J.W., Dozic S., Pandolfo M., Lamarche J., DiStefano L., Chang L.J. Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer's disease and in hereditary spinocerebellar ataxia disorders a nonspecific change? J. Neurochem. 72:1999;700-707.
8. Morrison B.M., Morrison J.H. Amyotrophic lateral sclerosis associated with mutations in superoxide dismutase a putative mechanism of degeneration . Brain Res. Rev. 29:1999;121-135.
9. Brown D.R., Qin K., Herms J.W., Madlung A., Manson J., Strome R., Fraser P.E., Kruck T., von Bohlen A., Schulz-Shaffer W., Giese A., Westaway D., Kretzschmar H. The cellular prion protein binds copper in vivo. Nature. 390:1997;684-687.
10. Pauly P.C., Harris D.A. Copper stimulates endocytosis of the prion protein. J. Biol. Chem. 273:1998;33107-33110.
11. Tatton W.G., Chalmers-Redman R.M.E., Ju W.Y.H., Wadia J., Tatton N.A. Apoptosis in neurodegenerative disorders potential for therapy by modifying gene transcription . J. Neural. Transm. 49:1997;245-268.
12. Leist M., Nicotera P. Apoptosis, excitotoxicity and neuropathology. Exp. Cell Res. 239:1998;183-201.
13. Miller L.J., Marx J. Apoptosis. Science (special section). 281:1998;1301-1326.
14. Sadoul R. Bcl-2 family members in the development and degenerative pathologies of the nervous system. Cell Death Differ. 5:1998;805-815.
15. Rossi L., Marchese E., De Martino A., Piccirilli S., Rotilio G., Ciriolo M.R. Neurodegeneration in the animal model of Menkes' disease involves Bcl-2-linked apoptosis. Neuroscience. 103:2001;181-188.
16. Prohaska J.R. Changes in Cu, Zn superoxide dismutase, cytochrome c oxidase, glutathione peroxidase and glutathione transferase activities in copper-deficient mice and rats. J. Nutr. 121:1991;355-363.
17. Rossi L., Ciriolo M.R., Marchese E., De Martino A., Giorgi M., Rotilio G. Differential decrease of copper content and of copper binding to superoxide dismutase in liver, heart and brain of copper-deficient rats. Biochem. Biophys. Res. Commun. 203:1994;1028-1039.
18. Brewer G.J. The treatment of Wilson's disease. Leone A., Mercer J.F.B. Copper transport and its disorders. 1999;115-126 Kluwer Acad/Plenum Publ, New York.
19. Walshe J.M. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Lancet. 2:1982;1401-1402.
20. Taylor R.W., Birch-Machin M.A., Bartlett K., Turnbull D.M. Succinate-cytochrome c reductase assessment of its value in the investigation of defects of the respiratory chain . Biochim. Biophys. Acta. 1181:1993;261-265.
21. Rigo A., Viglino P., Rotilio G. Polarographic determination of superoxide dismutase. Anal. Biochem. 68:1975;1-8.
22. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement by Folin-phenol reagent. J. Biol. Chem. 193:1951;265-275.
23. Reed D.J., Babson J.R., Beatty P.W., Brodie A.E., Ellis M.W., Potter D.W. High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide and related thiols and disulfides. Anal. Biochem. 106:1980;55-62.
24. Bus J.S., Gibson J.E. Paraquat model for oxidant-initiated toxicity . Environ. Health Perspect. 55:1984;37-46.
25. Li X., Sun A.Y. Paraquat induced activation of trascription factor AP-1 and apoptosis in PC12 cells. J. Neural Transm. 106:1999;1-21.
26. Kidd V.J. Proteolytic activities that mediate apoptosis. Annu. Rev. Physiol. 60:1998;533-573.
27. Mèplan C., Richard M.J., Hainaut P. Redox signalling and transition metals in the control of the p53 pathway. Biochem. Pharmacol. 59:2000;25-33.
28. Ciriolo M.R., De Martino A., Lafavia E., Rossi L., Carrì M.T., Rotilio G. Cu, Zn superoxide dismutase-dependent apoptosis induced by nitric oxide in neuronal cells. J. Biol. Chem. 275:2000;5065-5072.
29. Fiscella M., Ullrich S.J., Zambrano N., Shields M.T., Lin D., Lees-Miller S.P., Anderson C.W., Mercer W.E., Appella E. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activity. Oncogene. 8:1993;1519-1528.
30. Percival S.S., Layden-Patrice M. HL-60 cells can be made copper deficient by incubating with tetraethylenepentamine. J. Nutr. 122:1992;2424-2429.
31. Wu J.Y., Zhang J.J., Wang Y., Reaves S.K., Wang Y.R., Lei P.P. Regulation of apolipoprotein A-I gene expression in Hep G2 cells depleted of Cu by cupruretic tetramine. Am. J. Physiol. 273:1997;C1362-C1370.
32. Zhang J.J., Wang Y., Lai K.Y. Apolipoprotein A-I synthesis and secretion are increased in Hep G2 cells depleted of copper by cupruretic tetramine. J. Nutr. 125:1995;172-182.
33. Hopkins R.G., Failla M.L. Transcriptional regulation of interleukin-2 gene expression is impaired by copper deficiency in Jurkat human T lymhocytes. J. Nutr. 129:1999;596-601.
34. McArdle H.J., Gross S.M., Creaser I., Sargeson A.M., Danks D.M. Effect of chelators on copper metabolism and copper pools in mouse hepatocytes. Am. J. Physiol. 256:1989;G667-G672.
35. Tong K.K., Hannigan B.M., McKerr G., Strain J.J. The effects of copper-deficiency on human lymphoid and myeloid cells an in vitro model . Br. J. Nutr. 75:1996;97-108.
36. Rotilio G., Rossi L., De Martino A., DaCosta-Ferreira A.M., Ciriolo M.R. Free radicals, metal ions and oxidative stress chemical mechanisms of damage and protection in living systems . J. Braz. Chem. Soc. 6:1995;221-227.
37. Rossi L., Marchese E., De Martino A., Rotilio G., Ciriolo M.R. Purification of a fully metal depleted Cu, Zn superoxide dismutase from copper-deficient rat liver. Biometals. 10:1997;257-262.
38. Medeiros D.M., Davidson J., Jenkins J.E. A unified perspective on copper-deficiency and cardiomyopathy. Proc. Soc. Exp. Biol. Med. 203:1993;262-273.
39. Rossi L., Lippe G., Marchese E., De Martino A., Mavelli I., Rotilio G., Ciriolo M.R. Decrease of cytochrome c oxidase protein in heart mitochondria of copper-deficient rats. Biometals. 11:1998;207-212.
40. Medeiros D.M., Shiry L., Samelman T. Cardiac nuclear encoded cytochrome c oxidase subunits are decreased with copper restriction but not iron restriction gene expression, protein synthesis and heat shock protein aspects . Comp. Biochem. Physiol. A. Physiol. 117:1997;77-87.
41. Rao M.S., Yeldandi A.V., Subbarao V., Reddy J.K. Role of apoptosis in copper-deficiency-induced pancreatic involution in the rat. J. Pathol. 142:1993;1952-1957.
42. Tanaka H., Yamanouchi M., Imai S., Hayashi Y. Low copper and brain abnormalities in fetus from triethylene tetramine dihydrochloride-treated pregnant mouse. J. Nutr. Sci. Vitaminol. (Tokyo). 38:1992;545-554.
43. Buttke T.M., Sandstrom P.A. Oxidative stress as mediator of apoptosis. Immunol. Today. 15:1994;7-10.
44. Jacobson M.D. Reactive oxygen species and programmed cell death. Trends Biochem. Sci. 21:1996;83-86.
45. Gabbianelli R., Ferri A., Rotilio G., Carrì M.T. Aberrant copper chemistry as a major mediator of oxidative stress in human cellular model of amyotrophic lateral sclerosis. J. Neurochem. 73:1999;1175-1180.
46. Corasaniti M.T., Strongoli M.C., Rotiroti D., Bagetta G., Nisticò G. Paraquat a useful tool for the in vivo study of mechanisms of neuronal cell death . Pharmacol. Toxicol. 83:1998;1-7.
47. Ghibelli L., Fanelli C., Rotilio G., Lafavia E., Coppola S., Colussi C., Civitareale P., Ciriolo M.R. Rescue of cells from apoptosis by inhibition of active GSH extrusion. FASEB J. 12:1998;479-486.
48. Thornberry N.A., Lazebenik Y. Caspases enemy within . Science. 281:1998;1312-1316.
49. Matsura T., Kai M., Fujii Y., Ito H., Yamada K. Hydrogen peroxide-induced apoptosis in HL-60 cells requires caspase-3 activation. Free Radic. Res. 30:1999;73-83.